Technical Analysis for CLLS - Cellectis S.A.

Grade Last Price % Change Price Change
grade F 16.8 0.18% 0.03
CLLS closed down 2.9 percent on Thursday, January 17, 2019, on 1.31 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical CLLS trend table...

Date Alert Name Type % Chg
Jan 17 Fell Below 20 DMA Bearish 0.18%
Jan 16 Crossed Above 20 DMA Bullish -2.72%
Jan 16 Spinning Top Other -2.72%
Jan 16 Gapped Up Strength -2.72%
Jan 15 Inside Day Range Contraction 0.54%
Jan 14 Fell Below 20 DMA Bearish 1.82%
Jan 14 Gapped Down Weakness 1.82%
Jan 11 New Downtrend Bearish -8.30%
Jan 11 Stochastic Sell Signal Bearish -8.30%
Jan 11 Weak + Overbought Other -8.30%

Older signals for CLLS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Cellectis, a biopharmaceutical company, develops cancer products based on engineered T cells armed with a chimeric antigen receptor for the treatment of liquid and solid tumors. Its lead product candidate, UCART19, is an allogeneic engineered T cell product for the treatment of CD19 expressing hematologic malignancies that developed in chronic lymphocytic leukemia and acute lymphoblastic leukemia indications. The company's products also include hematopoietic tumors, such as UCART123 and UCART33 for acute myeloid leukemia indications, and UCART-BCMA and UCART38 for multiple myeloma indications, as well as solid tumors comprising UCART5T4 for various solid tumor indications and UCART-EgfrVIII for glioblastoma indications. In addition, it is focused on life sciences to build products based on genome engineering technologies in various fields and markets. Cellectis was founded in 1999 and is based in Paris, France.
Is CLLS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 38.85
52 Week Low 15.44
Average Volume 148,633
200-Day Moving Average 26.5947
50-Day Moving Average 20.1312
20-Day Moving Average 17.118
10-Day Moving Average 17.834
Average True Range 0.8319
ADX 29.01
+DI 20.9314
-DI 33.831
Chandelier Exit (Long, 3 ATRs ) 16.6843
Chandelier Exit (Short, 3 ATRs ) 17.9357
Upper Bollinger Band 19.17
Lower Bollinger Band 15.066
Percent B (%b) 0.42
BandWidth 23.974763
MACD Line -0.7035
MACD Signal Line -0.8575
MACD Histogram 0.154
Fundamentals Value
Market Cap 600.19 Million
Num Shares 35.8 Million
EPS -2.30
Price-to-Earnings (P/E) Ratio -7.29
Price-to-Sales 23.25
Price-to-Book 4.09
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.66
Resistance 3 (R3) 17.68 17.42 17.51
Resistance 2 (R2) 17.42 17.19 17.40 17.46
Resistance 1 (R1) 17.09 17.05 16.96 17.07 17.41
Pivot Point 16.83 16.83 16.76 16.81 16.83
Support 1 (S1) 16.50 16.60 16.37 16.48 16.13
Support 2 (S2) 16.24 16.46 16.22 16.08
Support 3 (S3) 15.91 16.24 16.03
Support 4 (S4) 15.89